Exploris Health
Exploris Health AG is a Swiss medical technology company that develops AI-based cardiovascular diagnostics. Its Cardio Explorer is an IVDR-cleared, non-invasive AI test using blood biomarkers and clinical data to detect coronary artery disease, serving hospitals, clinics, physicians, and insurers across Europe and the Middle East.
- Company typePrivate
- Founded2018
- HeadquartersWallisellen, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Exploris Health does
Exploris Health AG is a Swiss medical technology company founded in 2018 and headquartered in Wallisellen, Switzerland, that develops AI-based diagnostic and therapy solutions for cardiovascular disease. Its flagship product, Cardio Explorer, is a CE-marked, IVDR Class B software-as-a-medical-device that calculates a personalized pre-test probability for obstructive coronary artery disease by combining 15 laboratory blood biomarkers, ECG data, symptoms, and clinical risk factors. The product is positioned as a non-invasive rule-out tool for primary care, validated in three peer-reviewed studies with over 2,000 patients and achieving an AUC of 0.87 — comparable to cardiac CT and MRI — and serves hospitals, cardiologists, general practitioners, preventive medicine centers, corporate health programs, and patients with suspected chronic coronary syndrome across Switzerland, Germany, and the UAE.
The portfolio is anchored by Cardio Explorer and extends to Heart Failure Explorer (a personalized heart failure therapy solution under development) and an 'AI as a Service' offering built on the AI-X platform. The proprietary AI-enhanced multi-marker algorithm ingests structured clinical data and exposes an API for integration with electronic health records — most recently connected to Switzerland's electronic patient dossier through Post Sanela Health AG. Clinical validation has been conducted with academic partners including Universitätsspital Basel, Maastricht University Medical Centre (696-patient CVC study), and HGZ Bad Bevensen, and the algorithm has received EQUAL CARE certification for gender-balanced diagnostic performance.
Exploris Health generates revenue primarily through per-test transaction fees for Cardio Explorer screenings (approximately CHF 350 per screening in Switzerland) and increasingly through insurance reimbursement and strategic partnerships. The product is included in the supplementary coverage of major Swiss health insurers — Helsana Primeo (90% reimbursement up to CHF 5,000 per year) and CSS Gesundheitskonto — which broadens patient access and drives volume. Distribution is hybrid: direct physician and clinic sales in Switzerland and Germany, channel partners such as Sana Praevention (Munich/Frankfurt) and Alfadiag (UAE), and a flagship distribution agreement with Roche for global reach. The company has been awarded ISO 13485 certification (BSI, October 2025), the DMEA nova Award (2024), the Swiss InsurTech Hub Impact on Digital Health award (2024), and the InsureNXT Innovation Award (2025).
Exploris Health firmographics
Firmographics- Name
- Exploris Health
- Legal name
- Exploris Health AG
- Website
- https://explorishealth.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Exploris Health AG is a Swiss medical technology company that develops AI-based cardiovascular diagnostics. Its Cardio Explorer is an IVDR-cleared, non-invasive AI test using blood biomarkers and clinical data to detect coronary artery disease, serving hospitals, clinics, physicians, and insurers across Europe and the Middle East.
- Ownership category
- akta.pro rank
Exploris Health industry classification
Industry- Product category
- Cardiovascular Diagnostic Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Software Publishers (5132)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)
- akta.pro secondary industries
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Heart Failure & Transplant Cardiology (HLAKABAD)
Keywords
Where Exploris Health is headquartered
LocationHeadquarters
- HQ city
- Wallisellen
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Exploris Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Cardio Explorer Diagnostic Testing: Revenue generated from Cardio Explorer diagnostic tests performed at partner clinics and healthcare providers. Tests are ordered by physicians and billed through healthcare systems or reimbursed by insurance. Pricing approximately CHF 350 per screening in Switzerland.
- Insurance Reimbursement: Cardio Explorer is included in insurance reimbursement packages including Helsana Primeo (90% cost coverage) and CSS Gesundheitskonto. This enables patient access while generating revenue through insurance claim processing.
- Strategic Partnerships and Licensing: Partnership with Roche aims to enable global access to Cardio Explorer, potentially including licensing arrangements for international market expansion.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Cardio Explorer screening in Switzerland |
| Transaction based/ take rate | Pay-as-you-go | CSS Gesundheitskonto reimbursement package |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Exploris Health product offering
Product offeringCore offering
Exploris Health develops and sells AI-based medical device software for cardiovascular diagnostics and therapy. The flagship product, Cardio Explorer, is a CE-marked and IVDR Class B cleared Software as Medical Device (SaMD) that non-invasively detects obstructive coronary artery disease by combining 15 blood biomarkers, ECG data, symptoms, and clinical risk factors into a personalized pre-test probability score (AUC 0.87). The company also offers Heart Failure Explorer for personalized heart failure therapy and custom AI development services through its AI-X platform.
Product overview
Exploris Health is a Swiss medical technology company offering AI-based diagnostic and therapy solutions. The core product portfolio consists of Cardio Explorer (an IVDR-cleared AI diagnostic test for coronary artery disease), Heart Failure Explorer (personalized heart failure therapy), and AI as a Service capabilities built on the AI-X Platform. The company leverages proprietary multi-marker algorithms combining blood biomarkers, ECG data, and clinical parameters to provide personalized cardiovascular risk assessment. Cardio Explorer serves as the primary commercially available product, while Heart Failure Explorer and custom AI services are under development.
Differentiator
Problem solved
Functional benefit
Brands
- Cardio Explorer: AI-based diagnostic test for detecting obstructive coronary artery disease (CAD) and assessing heart attack risk. Non-invasive test using blood biomarkers, ECG data, symptoms, and clinical risk factors. CE-marked and validated in three clinical studies.
- Heart Failure Explorer
- KI als Service (AI as a Service)
Products and services
- Cardio Explorer A non-invasive AI-based diagnostic test (Software as Medical Device) that calculates personalized pre-test probability for obstructive coronary artery disease (CAD) using 15 blood biomarkers, ECG data, symptoms, and clinical risk factors. CE-marked and IVDR Class B cleared for use in the EU and UK. For physicians, cardiologists, hospitals, and preventive medicine centers.
- Heart Failure Explorer A personalized therapy solution for heart failure (Herzinsuffizienz) that enables patient self-treatment and optimizes therapy management. Part of Exploris Health's AI-based diagnostic and therapy solutions portfolio alongside Cardio Explorer.
- KI als Service (AI as a Service) Custom AI development services enabling rapid analysis of complex data structures and development of new applications through Exploris Health's AI-X platform. Provides data science and predictive modeling capabilities for healthcare and other sectors.
- AI-X Platform The technology platform supporting all Exploris Health AI solutions. Enables rapid analysis of complex data structures and development of new AI applications for healthcare diagnostics and therapy optimization. Sold as the foundation for the KI als Service offering.
Quantifiable outcome
- 96 out of 100 patients correctly identified as not having obstructive CAD when selecting low- and very-low-risk patients for rule-out
- +4 more outcomes
Companies that use Exploris Health
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Exploris Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature4 records
Exploris Health partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core, flagship and minor.
- Post Sanela Health AGcoreIntegration of Cardio Explorer into the electronic patient dossier (EPD) in Switzerland. Post Sanela Health AG offers EPD through Sanela Stammgemeinschaft, supporting secure healthcare networking. Results will be automatically and securely stored and accessible to patients and healthcare providers.
- RocheflagshipStrategic collaboration to improve cardiac diagnostics and enable worldwide access to Cardio Explorer. Partnership aims to contribute to timely diagnosis of coronary heart disease (KHK). Roche commits to investing in innovative solutions and AI to support efficient, evidence-based clinical decision-making.
- Medcare Hospitals & Medical CentrescoreMedcare Hospitals in UAE deploying Cardio Explorer for early detection of coronary heart disease. Dr. Brajesh Mittal, Head of Cardiology at Medcare Hospital Al Safa, noted Cardio Explorer as a 'game-changer for early intervention' enabling proactive care.
- AlfadiagminorSales partner in UAE region facilitating distribution and implementation of Cardio Explorer at Medcare Hospitals and other regional healthcare providers.
- Sana PraeventioncoreSana Praevention offers Cardio Explorer KI-Herz-Check-Up at Munich and Frankfurt locations as part of health check-up services for individuals and corporate clients. Part of Sana Kliniken AG, one of largest healthcare providers in German-speaking region.
- HelsanacoreHelsana Primeo supplementary insurance includes Cardio Explorer with 90% cost reimbursement. Up to CHF 5,000 per calendar year reimbursed for insured customers. First insurance partner to include Cardio Explorer in coverage.
- CSScoreCardio Explorer included in CSS 'Gesundheitskonto' reimbursement package. CSS supports innovative offerings to improve products for insured persons. CSS representative noted commitment to shaping future of healthcare system.
- Herz-Hirn-AllianzminorMembership in alliance of leading healthcare stakeholders including medical societies, patient organizations, health insurance companies, and industry representatives. Goal to reduce cardiovascular events in Germany by 30% by 2030.
- 5-HT Chemistry & HealthminorMembership platform connecting successful global players and hidden champions in chemistry and health with innovative startups. Provides networking, cooperation, and co-development opportunities with focus on digital innovation in Germany.
- DayOne Health 4.0 AcceleratorminorSelected for DayOne Health 4.0 Accelerator Cohort 2024, hosted by Roche. Access to accelerator resources, mentorship, and healthcare innovation network.
- Universitätsspital BaselcoreClinical validation partner with Prof. Michael Zellweger serving on Cardio Explorer Medical Advisory Board as Head of Non-Invasive Cardiology. Active research collaboration in non-invasive cardiac imaging and AI applications.
- Maastricht University Medical Centre (MUMC+)coreClinical validation site for CVC study with 696 patients. Prof. Hans-Peter Brunner-La Rocca serves on Medical Advisory Board as Vice Chairman, Department of Cardiology. Research collaboration in cardiology and heart failure.
- Herz- und Gefässzentrum (HGZ) Bad BevensencoreClinical partner with Prof. Bjoern Andrew Remppis contributing to Cardio Explorer publications. His work in molecular heart failure research and troponin-T test development influenced cardiology field.
- Boehringer IngelheimminorPharmaceutical partner shown in company logos, part of broader healthcare ecosystem partnerships for cardiovascular disease management.
- MedbaseminorHealthcare provider partner for Cardio Explorer campaigns and distribution in Swiss market.
- HirslandenminorSwiss hospital group partner shown in company logos for healthcare delivery partnerships.
Scale indicators4 records
Recent moves6 records
Expansion highlights7 records
Exploris Health competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Siemens Healthineers provides cardiac CT, MRI, and AI-enabled diagnostic software, offering broad incumbency alternatives to Cardio Explorer's non-imaging CAD pre-screening test.
- GE HealthCare: GE HealthCare is a large incumbent in cardiac imaging, ECG, and AI-augmented diagnostics, providing overlapping but broader alternatives to Cardio Explorer's focused CAD pre-screening.
- Philips: Philips offers cardiac imaging, monitoring, and AI-driven cardiology solutions as part of a broader connected-care portfolio, addressing the same hospital cardiology workflows as Cardio Explorer.
Direct peers
- Cleerly: Cleerly applies AI to coronary CTA to characterize plaque and identify obstructive CAD, competing directly with Cardio Explorer for the pre-screening and risk-stratification step before invasive testing.
- Elucid Bioimaging: Elucid develops AI-based vascular imaging analysis for cardiovascular disease characterization, overlapping with Cardio Explorer's goal of non-invasive CAD detection and risk stratification.
- HeartFlow: HeartFlow provides AI-driven FFR-CT analysis for obstructive coronary artery disease, addressing the same CAD detection workflow as Cardio Explorer but using non-invasive cardiac CT imaging rather than blood biomarkers and ECG.
Emerging players
- Eko Health: Eko Health combines digital stethoscopes and AI-enabled ECG analysis for cardiac screening in primary care, an adjacent but overlapping approach to Cardio Explorer's algorithm-based cardiac assessment.
- AliveCor: AliveCor's KardiaMobile and KardiaAI platforms deliver AI-interpreted consumer ECG for arrhythmia and cardiac risk screening, comparable to Cardio Explorer's goal of broadening access to AI-driven cardiac diagnostics.
- Anumana: Anumana applies AI to ECG signals to surface hidden cardiac conditions, sharing Cardio Explorer's emphasis on algorithmic interpretation of cardiac signals for early disease detection.
- Aidoc: Aidoc provides AI imaging decision-support across multiple specialties including cardiology, competing for the same hospital IT budgets and workflow integration slots that Cardio Explorer targets via its API.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Exploris Health social profiles
Digital presenceExploris Health compliance and trust
Trust signalCompliance5 records
Exploris Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exploris Health leadership team
Management profileNumber of profiles
Profiles10 records
Exploris Health funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exploris Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exploris Health
What does Exploris Health do?
Exploris Health develops and sells AI-based medical device software for cardiovascular diagnostics and therapy. The flagship product, Cardio Explorer, is a CE-marked and IVDR Class B cleared Software as Medical Device (SaMD) that non-invasively detects obstructive coronary artery disease by combining 15 blood biomarkers, ECG data, symptoms, and clinical risk factors into a personalized pre-test probability score (AUC 0.87). The company also offers Heart Failure Explorer for personalized heart failure therapy and custom AI development services through its AI-X platform.
Is Exploris Health a public or private company?
Exploris Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Exploris Health founded?
Exploris Health was founded in 2018. It employs 11 to 50 people.
Where is Exploris Health based?
Exploris Health is headquartered in Wallisellen, Switzerland, in the Europe region.
How does Exploris Health make money?
Three revenue lines are on record. Cardio Explorer Diagnostic Testing is the primary driver. The others are insurance Reimbursement and strategic Partnerships and Licensing.
Who are Exploris Health's main competitors?
Broad incumbents on record are Siemens Healthineers, GE HealthCare and Philips. Direct peers are Cleerly, Elucid Bioimaging and HeartFlow. Emerging players are Eko Health, AliveCor, Anumana and Aidoc.
Does Exploris Health have an API?
Yes. Cardio Explorer offers an API for automated patient data analysis. Patient data can be entered manually or seamlessly synced through the API for automated analysis. The API supports integration with lab systems for uploading blood panel data and importing clinical parameters from records.
What industry is Exploris Health in?
Exploris Health's product category is Cardiovascular Diagnostic Software. Its primary akta.pro industry code is HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 334510 and its SIC code is 3845.